The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Racial disparity in oncologic and patient-reported quality of life (PROs) outcomes in patients with locally advanced head and neck squamous cell carcinomas (HNSCC) enrolled in a randomized phase II trial.
 
Margaret Winn Kendrick
No Relationships to Disclose
 
Mary Weber Redman
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Millennium (Inst)
 
Kelsey K. Baker
No Relationships to Disclose
 
Renato G. Martins
Research Funding - Eisai (Inst); Genentech (Inst); Lilly (Inst); Pfizer (Inst)
 
Keith D. Eaton
Research Funding - Mirati Therapeutics (Inst); Pfizer (Inst); Resolution Bioscience (Inst)
 
Laura Quan Man Chow
Honoraria - Amgen; Astellas Pharma; Emergent BioSolutions; Merck; Novartis
Consulting or Advisory Role - Amgen; Emergent BioSolutions; Merck; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Lilly/ImClone (Inst); Merck (Inst); NCCN/Glaxo-Smith Kline (Inst); Novartis (Inst); Pfizer (Inst); VentiRx (Inst)
Travel, Accommodations, Expenses - Merck; Novartis
 
Rafael Santana-Davila
Consulting or Advisory Role - Eisai; Seagen
Research Funding - Genentech (Inst); Lilly (Inst)
 
Christina S. Baik
Consulting or Advisory Role - Novartis
Research Funding - Celgene (Inst); Clovis Oncology (Inst); Incyte (Inst); Millennium (Inst); Novartis (Inst)
 
Bernardo H. L. Goulart
No Relationships to Disclose
 
Sylvia Mina Lee
Research Funding - Juno Therapeutics (Inst)
 
Cristina P. Rodriguez
Research Funding - Karyopharm Therapeutics (Inst); Merck (Inst)